Glanbia Q1 Beat Raises Guidance, Shares Surge

Glanbia PLC shares jumped about 8.6% after Q1 2026 revenue grew 7.2% YoY, beating the 4.6% consensus.
Performance Nutrition and Health & Nutrition divisions posted 11.5% and 11.6% like‑for‑like growth, driven by 18.8% Optimum Nutrition sales and a 23.4% international surge.
The company lifted full‑year adjusted EPS guidance to the top of its 7‑11% range (mid‑point 9%) and raised Dairy Nutrition EBITDA outlook to $160‑170 million.
It also upgraded Performance Nutrition organic sales growth guidance to the upper end of its 5‑7% medium‑term range and applied double‑digit price hikes in April.